NYSE:VEEV Veeva Systems (VEEV) Stock Price, News & Analysis → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free VEEV Stock Alerts $203.49 +2.06 (+1.02%) (As of 05/3/2024 ET) Add Compare Share Share Today's Range$202.03▼$205.5250-Day Range$198.37▼$234.7952-Week Range$160.21▼$236.90Volume646,413 shsAverage Volume884,814 shsMarket Capitalization$32.83 billionP/E Ratio63.20Dividend YieldN/APrice Target$234.90 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Get Veeva Systems alerts: Email Address Veeva Systems MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.65 Rating ScoreUpside/Downside15.4% Upside$234.90 Price TargetShort InterestHealthy1.44% of Shares Sold ShortDividend StrengthN/ASustainability-0.79Upright™ Environmental ScoreNews Sentiment1.29Based on 6 Articles This WeekInsider TradingSelling Shares$4.82 M Sold Last QuarterProj. Earnings Growth14.36%From $4.11 to $4.70 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.78 out of 5 starsMedical Sector337th out of 5,430 stocksHealth Information Services Industry1st out of 18 stocks 3.3 Analyst's Opinion Consensus RatingVeeva Systems has received a consensus rating of Moderate Buy. The company's average rating score is 2.65, and is based on 14 buy ratings, 5 hold ratings, and 1 sell rating.Amount of Analyst CoverageVeeva Systems has been the subject of 15 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 4.0 Short Interest Percentage of Shares Shorted1.44% of the outstanding shares of Veeva Systems have been sold short.Short Interest Ratio / Days to CoverVeeva Systems has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Veeva Systems has recently decreased by 2.51%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldVeeva Systems does not currently pay a dividend.Dividend GrowthVeeva Systems does not have a long track record of dividend growth. Previous Next 2.9 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreVeeva Systems has received a 24.04% net impact score from Upright. Veeva Systems seems to create the most significant positive value in categories "Jobs", "Taxes", and "Knowledge infrastructure". The positive contribution in the "Knowledge infrastructure" impact category is false driven by its "Hosted data storage services", "Application hosting services", and "Hosted analytics services" products. See details.Environmental SustainabilityThe Environmental Impact score for Veeva Systems is -0.79. Previous Next 2.9 News and Social Media Coverage News SentimentVeeva Systems has a news sentiment score of 1.29. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.43 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Veeva Systems this week, compared to 11 articles on an average week.Search Interest20 people have searched for VEEV on MarketBeat in the last 30 days. This is an increase of 54% compared to the previous 30 days.MarketBeat FollowsOnly 10 people have added Veeva Systems to their MarketBeat watchlist in the last 30 days. This is a decrease of -52% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Veeva Systems insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $4,818,013.00 in company stock.Percentage Held by Insiders10.98% of the stock of Veeva Systems is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions88.20% of the stock of Veeva Systems is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for Veeva Systems are expected to grow by 14.36% in the coming year, from $4.11 to $4.70 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Veeva Systems is 63.20, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 144.90.Price to Earnings Ratio vs. SectorThe P/E ratio of Veeva Systems is 63.20, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 259.19.Price to Earnings Growth RatioVeeva Systems has a PEG Ratio of 2.01. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioVeeva Systems has a P/B Ratio of 7.07. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Stansberry ResearchGold ManiaFormer Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite).See his free reveal right here. About Veeva Systems Stock (NYSE:VEEV)Veeva Systems Inc. provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States. The company also provides Veeva Development Cloud, a suite of applications for the clinical, regulatory, quality, and safety functions, including Veeva Vault Clinical, Veeva Vault RIM, Veeva Vault Safety, and Veeva Vault Quality; Veeva QualityOne, a quality and document management, and training solution; Veeva RegulatoryOne, a solution that helps companies to manage regulatory submission content; and Veeva Claims addresses the end-to-end product and marketing claims management process. In addition, it offers professional and support services, including implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; data migration and systems integrations technical consulting services; training on its solutions; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.Read More VEEV Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart VEEV Stock News HeadlinesApril 24, 2024 | insidertrades.comAlan Mateo Sells 3,391 Shares of Veeva Systems Inc. (NYSE:VEEV) StockApril 19, 2024 | insidertrades.comJonathan Faddis Sells 3,598 Shares of Veeva Systems Inc. (NYSE:VEEV) StockMay 4, 2024 | Porter & Company (Ad)Elon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.May 2, 2024 | finance.yahoo.comQ1 2024 Energy Recovery Inc Earnings CallApril 24, 2024 | finance.yahoo.comInvesting in Veeva Systems (NYSE:VEEV) five years ago would have delivered you a 45% gainApril 24, 2024 | americanbankingnews.comVeeva Systems Inc. (NYSE:VEEV) EVP Alan Mateo Sells 3,391 Shares of StockApril 23, 2024 | prnewswire.comTop Biopharma Brands Reach Audiences 10x More Qualified with Veeva Crossix Prime SegmentsApril 22, 2024 | tmcnet.comDigital Asset Management Market worth $10.3 billion by 2029 - Exclusive Report by MarketsandMarkets™May 4, 2024 | Porter & Company (Ad)Elon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.April 19, 2024 | benzinga.comHow Is The Market Feeling About Veeva Systems?April 18, 2024 | finance.yahoo.comVeeva Launches AI Partner ProgramApril 18, 2024 | finance.yahoo.comDeclining Stock and Solid Fundamentals: Is The Market Wrong About Veeva Systems Inc. (NYSE:VEEV)?April 18, 2024 | seekingalpha.comVeeva Systems: Strong Reasons To Buy And Hold The SharesApril 17, 2024 | finance.yahoo.comVeeva Systems (VEEV) Stock Moves -0.58%: What You Should KnowApril 17, 2024 | finance.yahoo.comBiopharma Leaders Come Together at Veeva Commercial Summit to Advance Customer-Centric EngagementApril 17, 2024 | finance.yahoo.comVeeva Announces Vault CRM Campaign ManagerApril 10, 2024 | markets.businessinsider.comVeeva Systems: Poised for Growth with Strong Market Position and Competitive EdgeApril 10, 2024 | fool.com2 Healthcare Stocks to Buy Hand Over Fist in AprilApril 9, 2024 | bizjournals.comMental health provider shutters Redwood City operationsApril 9, 2024 | markets.businessinsider.comMaintaining Hold on Veeva Systems Amid New Salesforce Competition and Market UncertaintyApril 9, 2024 | markets.businessinsider.comMaintaining Leadership: Buy Rating Affirmed for Veeva Systems Amid Competitive PressuresApril 4, 2024 | bizjournals.comZendesk's long-time Mid-Market headquarters listed for saleApril 3, 2024 | finance.yahoo.comIs Veeva Systems (VEEV) a Good Investment Bet?April 2, 2024 | finance.yahoo.comVeeva Systems Inc.: Veeva: Leadership Transition Doesn’t Alter Our Favorable Long-Term OutlookApril 2, 2024 | msn.comWhy Veeva Systems Shares Are Diving TuesdayApril 2, 2024 | finance.yahoo.comVeeva Systems Stock Falls 7% After Finance Chief Steps DownApril 2, 2024 | msn.comKemwell BioPharma Drives Quality Excellence with Veeva Vault QMSSee More Headlines Receive VEEV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Veeva Systems and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/29/2024Today5/04/2024Next Earnings (Estimated)5/29/2024Fiscal Year End1/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorComputer and Technology Industry Prepackaged software Sub-IndustryN/A Current SymbolNYSE:VEEV CUSIPN/A CIK1393052 Webwww.veeva.com Phone(925) 452-6500Fax925-452-6504Employees7,172Year Founded2007Price Target and Rating Average Stock Price Target$234.90 High Stock Price Target$270.00 Low Stock Price Target$160.00 Potential Upside/Downside+15.4%Consensus RatingModerate Buy Rating Score (0-4)2.65 Research Coverage20 Analysts Profitability EPS (Most Recent Fiscal Year)$3.22 Trailing P/E Ratio63.20 Forward P/E Ratio49.51 P/E Growth2.03Net Income$525.71 million Net Margins22.24% Pretax Margin24.88% Return on Equity11.26% Return on Assets9.01% Debt Debt-to-Equity RatioN/A Current Ratio4.24 Quick Ratio4.24 Sales & Book Value Annual Sales$2.36 billion Price / Sales13.89 Cash Flow$3.52 per share Price / Cash Flow57.75 Book Value$28.80 per share Price / Book7.07Miscellaneous Outstanding Shares161,320,000Free Float143,604,000Market Cap$32.83 billion OptionableOptionable Beta0.76 Social Links Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Peter P. Gassner (Age 59)Founder, CEO & Director Comp: $420.83kMs. Eleni Nitsa Zuppas (Age 54)President & Chief of Staff Comp: $420.83kMr. Thomas D. Schwenger (Age 56)President & Chief Customer Officer Comp: $420.83kMr. Timothy Stephen Cabral (Age 57)Interim CFO & Director Comp: $50kMr. Brent R. Bowman (Age 57)Executive officer Comp: $420.83kMs. Kristine B. Diamond (Age 56)Principal Accounting Officer Mr. Matthew Robinson (Age 50)Chief Technology Officer Mr. Pinal PatelChief Information OfficerMr. Gunnar Georg HansenDirector of Investor RelationsMr. Jonathan W. Faddis (Age 52)Senior VP, General Counsel & Corporate Secretary Comp: $391.67kMore ExecutivesKey CompetitorsHubSpotNYSE:HUBSCloudflareNYSE:NETANSYSNASDAQ:ANSSMongoDBNASDAQ:MDBDatadogNASDAQ:DDOGView All CompetitorsInsiders & InstitutionsTeam Hewins LLCSold 138 shares on 5/4/2024Ownership: 0.001%Boomfish Wealth Group LLCSold 306 shares on 5/3/2024Ownership: 0.006%TFB Advisors LLCBought 73 shares on 5/3/2024Ownership: 0.002%Central Pacific Bank Trust DivisionBought 450 shares on 5/3/2024Ownership: 0.000%Larson Financial Group LLCBought 150 shares on 5/3/2024Ownership: 0.000%View All Insider TransactionsView All Institutional Transactions Should I Buy Veeva Systems Stock? VEEV Pros and Cons Explained Pros Here are some ways that investors could benefit from investing in Veeva Systems Inc.: Veeva Systems provides cloud-based software tailored for the life sciences industry, offering solutions like Veeva Commercial Cloud and Veeva Vault PromoMats, catering to the specific needs of pharmaceutical and biotechnology companies. Veeva's suite of software includes Veeva customer relationship management (CRM) which enables customer-facing employees to enhance interactions with clients, potentially leading to increased sales and customer satisfaction. The company's focus on analytics solutions like Veeva Crossix and Veeva OpenData can provide valuable insights for pharmaceutical brands, aiding in strategic decision-making and market positioning. Veeva's diverse product offerings, such as Veeva Vault Medical and Veeva Link, showcase the company's commitment to innovation and addressing the evolving needs of the life sciences industry. Considering the recent positive market sentiment towards Veeva Systems, reflected in its stock price performance, investors may find potential for capital appreciation and returns on their investment. Cons Investors should be bearish about investing in Veeva Systems Inc. for these reasons: While Veeva Systems has shown strong performance, the competitive landscape in the cloud-based software industry, especially in the life sciences sector, could pose challenges for sustained growth and market share expansion. Market volatility and fluctuations in the technology sector may impact Veeva's stock price, potentially leading to short-term uncertainties for investors. Regulatory changes or shifts in the healthcare industry could affect Veeva's business operations and product demand, introducing risks related to compliance and market dynamics. Investors should carefully assess Veeva's financial metrics, market positioning, and growth strategies to ensure alignment with their investment objectives and risk tolerance. External factors like global economic conditions or geopolitical events may influence Veeva Systems' performance and stock price, requiring investors to stay informed and proactive in their investment decisions. These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, April 10, 2024. Please send any questions or comments about these Veeva Systems pros and cons to contact@marketbeat.com. VEEV Stock Analysis - Frequently Asked Questions Should I buy or sell Veeva Systems stock right now? 20 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Veeva Systems in the last twelve months. There are currently 1 sell rating, 5 hold ratings and 14 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" VEEV shares. View VEEV analyst ratings or view top-rated stocks. What is Veeva Systems' stock price target for 2024? 20 brokerages have issued twelve-month price objectives for Veeva Systems' shares. Their VEEV share price targets range from $160.00 to $270.00. On average, they expect the company's stock price to reach $234.90 in the next year. This suggests a possible upside of 15.4% from the stock's current price. View analysts price targets for VEEV or view top-rated stocks among Wall Street analysts. How have VEEV shares performed in 2024? Veeva Systems' stock was trading at $192.52 at the beginning of the year. Since then, VEEV shares have increased by 5.7% and is now trading at $203.49. View the best growth stocks for 2024 here. When is Veeva Systems' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 29th 2024. View our VEEV earnings forecast. How were Veeva Systems' earnings last quarter? Veeva Systems Inc. (NYSE:VEEV) posted its earnings results on Thursday, February, 29th. The technology company reported $0.92 EPS for the quarter, beating analysts' consensus estimates of $0.81 by $0.11. The technology company earned $630.62 million during the quarter, compared to analyst estimates of $620.75 million. Veeva Systems had a trailing twelve-month return on equity of 11.26% and a net margin of 22.24%. What ETFs hold Veeva Systems' stock? ETFs with the largest weight of Veeva Systems (NYSE:VEEV) stock in their portfolio include First Trust Nasdaq Lux Digital Health Solutions ETF (EKG), VanEck Morningstar Wide Moat Growth ETF (MGRO), Fidelity Digital Health ETF (FDHT), Sterling Capital Focus Equity ETF (LCG), iShares U.S. Healthcare Providers ETF (IHF), Vesper U.S. Large Cap Short-Term Reversal Strategy ETF (UTRN), Direxion Daily Cloud Computing Bull 2x (CLDL) and ARK Genomic Revolution ETF (ARKG). What guidance has Veeva Systems issued on next quarter's earnings? Veeva Systems issued an update on its first quarter 2025 earnings guidance on Friday, April, 19th. The company provided EPS guidance of for the period. The company issued revenue guidance of $640.0 million-$643.0 million, compared to the consensus revenue estimate of $641.9 million. What is Peter Gassner's approval rating as Veeva Systems' CEO? 202 employees have rated Veeva Systems Chief Executive Officer Peter Gassner on Glassdoor.com. Peter Gassner has an approval rating of 82% among the company's employees. What other stocks do shareholders of Veeva Systems own? Based on aggregate information from My MarketBeat watchlists, some companies that other Veeva Systems investors own include NVIDIA (NVDA), Alibaba Group (BABA), Salesforce (CRM), PayPal (PYPL), Shopify (SHOP), Walt Disney (DIS), Adobe (ADBE), Netflix (NFLX), Trade Desk (TTD) and Block (SQ). Who are Veeva Systems' major shareholders? Veeva Systems' stock is owned by a variety of retail and institutional investors. Top institutional investors include Van ECK Associates Corp (1.20%), Bank of New York Mellon Corp (0.51%), Allspring Global Investments Holdings LLC (0.46%), Sumitomo Mitsui Trust Holdings Inc. (0.25%), Riverbridge Partners LLC (0.25%) and Peregrine Capital Management LLC (0.16%). Insiders that own company stock include Alan Mateo, Eleni Nitsa Zuppas, Jonathan Faddis, Joseph Christopher Hays, Mary Lynne Hedley, Matthew J Wallach, Matthew J Wallach, Michele O'connor, Paul Edward Chamberlain, Paul J Sekhri, Peter P Gassner, Ronald E F Codd, Steven L Fasman, Thomas D Schwenger and Timothy S Cabral. View institutional ownership trends. How do I buy shares of Veeva Systems? Shares of VEEV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. Does Veeva Systems have any subsidiaries? The following companies are subsidiares of Veeva Systems: AdvantageMS, Learnaboutgmp, Physicians World, Selligy, Veeva Crossix, Veeva RTSM, Veracity Logic, and Zinc Ahead Ltd.Read More This page (NYSE:VEEV) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchAutomatic Income (from home)Awesomely, LLCClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsCould Your Accounts Be Frozen?Allegiance GoldFW: 234x GainWeiss RatingsStock-Picking AI Predicts #1 Stock of 2024Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Veeva Systems Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.